Share Facebook Twitter LinkedIn Pinterest Email Appfolio outlines 2025 revenue guidance of $920M-$940M with focus on innovation and partnerships
How mazdutide compares against weight loss therapies from Novo Nordisk, Lilly (NVO:NYSE)June 30, 2025